These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 27222125)
1. Tau mis-splicing in the pathogenesis of neurodegenerative disorders. Park SA; Ahn SI; Gallo JM BMB Rep; 2016 Aug; 49(8):405-13. PubMed ID: 27222125 [TBL] [Abstract][Full Text] [Related]
2. Tau mis-splicing correlates with motor impairments and striatal dysfunction in a model of tauopathy. Damianich A; Facal CL; Muñiz JA; Mininni C; Soiza-Reilly M; Ponce De León M; Urrutia L; Falasco G; Ferrario JE; Avale ME Brain; 2021 Sep; 144(8):2302-2309. PubMed ID: 34059893 [TBL] [Abstract][Full Text] [Related]
3. Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders. Janke C; Beck M; Stahl T; Holzer M; Brauer K; Bigl V; Arendt T Brain Res Mol Brain Res; 1999 May; 68(1-2):119-28. PubMed ID: 10320789 [TBL] [Abstract][Full Text] [Related]
4. Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy. Espíndola SL; Damianich A; Alvarez RJ; Sartor M; Belforte JE; Ferrario JE; Gallo JM; Avale ME Cell Rep; 2018 Apr; 23(3):709-715. PubMed ID: 29669277 [TBL] [Abstract][Full Text] [Related]
5. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Buée L; Bussière T; Buée-Scherrer V; Delacourte A; Hof PR Brain Res Brain Res Rev; 2000 Aug; 33(1):95-130. PubMed ID: 10967355 [TBL] [Abstract][Full Text] [Related]
6. Tau Isoforms: Gaining Insight into Corsi A; Bombieri C; Valenti MT; Romanelli MG Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499709 [TBL] [Abstract][Full Text] [Related]
7. The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes. Buchholz S; Zempel H Alzheimers Dement; 2024 May; 20(5):3606-3628. PubMed ID: 38556838 [TBL] [Abstract][Full Text] [Related]
8. Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing. Avale ME; Rodríguez-Martín T; Gallo JM Hum Mol Genet; 2013 Jul; 22(13):2603-11. PubMed ID: 23459933 [TBL] [Abstract][Full Text] [Related]
9. Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Andreadis A Biochim Biophys Acta; 2005 Jan; 1739(2-3):91-103. PubMed ID: 15615629 [TBL] [Abstract][Full Text] [Related]
10. The role of MAPT sequence variation in mechanisms of disease susceptibility. Caffrey TM; Wade-Martins R Biochem Soc Trans; 2012 Aug; 40(4):687-92. PubMed ID: 22817717 [TBL] [Abstract][Full Text] [Related]
11. High-resolution temporal and regional mapping of MAPT expression and splicing in human brain development. Hefti MM; Farrell K; Kim S; Bowles KR; Fowkes ME; Raj T; Crary JF PLoS One; 2018; 13(4):e0195771. PubMed ID: 29634760 [TBL] [Abstract][Full Text] [Related]
12. The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy. Zhang CC; Xing A; Tan MS; Tan L; Yu JT Mol Neurobiol; 2016 Sep; 53(7):4893-904. PubMed ID: 26363795 [TBL] [Abstract][Full Text] [Related]
13. [Tau story: from frontotemporal dementia to other tauopathies]. Buée L; Hamdane M; Delobel P; Sambo AV; Bégard S; Ghestem A; Sergeant N; Delacourte A J Soc Biol; 2002; 196(1):103-8. PubMed ID: 12134624 [TBL] [Abstract][Full Text] [Related]
14. Lack of association between TDP-43 pathology and tau mis-splicing in Alzheimer's disease. Niblock M; Hortobágyi T; Troakes C; Al-Sarraj S; Spickett C; Jones R; Shaw CE; Gallo JM Neurobiol Aging; 2016 Jan; 37():45-46. PubMed ID: 26507309 [TBL] [Abstract][Full Text] [Related]
15. Microtubule-associated protein tau in development, degeneration and protection of neurons. Wang JZ; Liu F Prog Neurobiol; 2008 Jun; 85(2):148-75. PubMed ID: 18448228 [TBL] [Abstract][Full Text] [Related]
16. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)]. Kowalska A Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823 [TBL] [Abstract][Full Text] [Related]
17. Structural basis for stabilization of the tau pre-mRNA splicing regulatory element by novantrone (mitoxantrone). Zheng S; Chen Y; Donahue CP; Wolfe MS; Varani G Chem Biol; 2009 May; 16(5):557-66. PubMed ID: 19477420 [TBL] [Abstract][Full Text] [Related]
18. Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway. Chen KL; Yuan RY; Hu CJ; Hsu CY Neurobiol Dis; 2010 Nov; 40(2):378-85. PubMed ID: 20615469 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765 [TBL] [Abstract][Full Text] [Related]
20. Altered splicing of Tau in DM1 is different from the foetal splicing process. Ghanem D; Tran H; Dhaenens CM; Schraen-Maschke S; Sablonnière B; Buée L; Sergeant N; Caillet-Boudin ML FEBS Lett; 2009 Feb; 583(4):675-9. PubMed ID: 19166838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]